Tharimmune appoints Clay Kahler, Gary Stetz to board of directors

Tharimmune (THAR) announced the appointment of Clay Kahler and Gary Stetz to its Board of Directors, increasing the Tharimmune Board to nine Directors. As reported in a Form 8-K filed on April 25, 2025, Directors Leonard Mazur and Lynne Bui, M.D. have notified the Board that they will not seek re-election at the Company’s 2025 Annual Meeting of Stockholders on June 10, at which time the size of the Board will decline to seven Directors. Mr. Kahler will serve on the audit and nominating and corporate governance committees and chair the compensation committee and Mr. Stetz will serve on the compensation and audit committees and chair the nominating and corporate governance committee. Kahler is the Co-founder, CEO, and Managing Director of Spray Labs. Stetz currently serves as Managing Partner of Stetz, Belgiovine, Manwarren and Wallis P.C.